OnKure Therapeutics (OKUR) Stock: Buy, Sell, or Hold?
OKUR - OnKure Therapeutics, Inc. Class A Common Stock
$2.52
-0.06 (-2.33%)
âŧ
5d:
+20.0%
30d:
-13.99%
90d:
-37.78%
WAIT
LOW Confidence
Analysis Updated: Oct 23, 2026 12:00 AM ET
Earnings: Nov 05, 2026
11d
Get Alerted When OKUR Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
âšī¸ NEUTRAL: OKUR is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
âšī¸ NEUTRAL: OKUR is fairly priced but lacks strong directional signals. Wait for clearer setup or better entry on dips.
In-depth Analysis How we analyze
Valuation Analysis: OKUR is currently trading at $2.52, which is considered fair relative to its 30-day fair value range of $2.31 to $2.90.
Technical Outlook: Technically, OKUR is in a strong downtrend. Immediate support is located at $2.01, while resistance sits at $2.62.
Market Sentiment: The stock scores a mixed 59/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $15.50 (+515.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, OKUR is in a strong downtrend. Immediate support is located at $2.01, while resistance sits at $2.62.
Market Sentiment: The stock scores a mixed 59/100 on our bottoming-setup gauge, with only partial signs of a stabilized entry point. Wall Street analysts see significant upside, with an average price target of $15.50 (+515.1%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
FAIR
Historical Trading Range
$2.31 -
$2.90
Company Quality Score
52/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- NEUTRAL: Price in fair range
- NEUTRAL: Mixed technical signals (59/100)
- BULLISH: High volume confirmation
- BULLISH: Trading 515.1% below Wall St target ($15.50)
- WARNING: Composite score 52/100 in the bottom quintile â this cohort historically lags the market
Trading Range Analysis
30-Day Trading Range
$2.31 -
$2.90
Current vs Trading Range
FAIR
Support & Resistance Levels
Support Level
$2.01
Resistance Level
$2.62
Current Trend
Strong Downtrend
Technical data as of
Oct 23, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-1.65
Wall Street Target
$15.50
(+515.1%)
Share & Embed Analysis
Last updated: October 23, 2026 7:43 PM ET
Data refreshes hourly during market hours. Next update: 8:43 PM
Data refreshes hourly during market hours. Next update: 8:43 PM
đĨ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is OKUR showing a specific setup today?
Insider Activity (6 Months)
0
Buys
0
Sells
0
Net
NEUTRAL
Top Rated Biotechnology Stocks
Top-rated stocks in Biotechnology by analyst ratings.
| Stock | Analyst Consensus | Analyst Target | Tradestie Score |
|---|---|---|---|
|
VRTX
Vertex Pharmaceuticals IâĻ |
STRONG BUY
32 analysts |
$571 | 58 HOLD |
|
ALNY
Alnylam Pharmaceuticals âĻ |
STRONG BUY
30 analysts |
$369 | 52 HOLD |
|
ONC
BeiGene, Ltd. |
STRONG BUY
27 analysts |
$436 | 38 SELL |
|
ASND
Ascendis Pharma AS |
STRONG BUY
21 analysts |
$307 | 51 HOLD |
|
RYTM
Rhythm Pharmaceuticals IâĻ |
STRONG BUY
18 analysts |
$144 | 75 BUY |
